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Spinal Cord Stimulation  
for Control of Pain
Stephen Falowski, MD
Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania
Introduction
Spinal cord stimulation (SCS) is an adjustable, non-destructive procedure which delivers therapeutic 
doses of electrical current to the spinal cord for the management of neuropathic pain. The most 
common indications include post-laminectomy (“failed back surgery”) syndrome, complex regional 
pain syndrome (CRPS), ischemic limb pain, and angina. Other reported applications include 
visceral/abdominal pain, cervical neuritis pain, spinal cord injury pain, post-herpetic neuralgia, and 
neurogenic thoracic outlet syndrome. 
History
Advances in technology have driven the popularity of the field. Initially, the contact combinations 
could only be hardwired, and could not be reprogrammed after the pulse generator was implanted. 
In the beginning, only radio-frequency (RF) driven passive receivers were available. In the mid-
seventies, the first implantable pulse generator powered by a lithium battery was introduced into the 
market. In 1980, the first percutaneous electrode was produced, and this could be reprogrammed 
non-invasively through an external transmitter.1
Mechanisms of Action
SCS began when Melzack and Wall2 noted that stimulation of large peripheral nerve fibers could 
block the sensation of pain. In 1967, Shealy3 inserted the first dorsal column stimulator in a 
human suffering from terminal metastatic cancer. Later approaches implanted electrodes via a 
laminectomy in the subarachnoid space, between the two layers of the dura, or in the epidural 
space.4-6 Subsequently, less invasive percutaneous techniques were introduced.7
The exact mechanisms of action of SCS remain unclear, although computer modeling work has 
shed some light on the distribution of complex electrical fields within the spine.8-13 Animal studies 
suggest that the SCS triggers the release of serotonin, substance P, and GABA within the dorsal 
horn.14, 15 It is not known whether stimulation of different sites—peripheral nerves, dorsal columns, 
or supra-lemniscal pathways—will trigger equivalent mechanisms of action. 
Indications
SCS has been successfully used for a variety of pain conditions (Table I). Experience suggests that, 
in selected patients, SCS can produce at least 50% pain relief in 50-60% of the implanted patients. 
Interestingly, with the proper follow-up care, these results can be maintained over several years. 
Complex Regional Pain Syndrome (CRPS)
The implementation of SCS in individuals with CRPS type I is more difficult than with any other 
patients groups. There is risk of aggravating the original pain or causing a new pain at the implanted 
hardware site is greater than with any other diagnostic category mentioned. The CPRS-affected areas 
may be too widespread for effective stimulation.
In 1989, Barolat et al. reported reduction of pain in ten out of thirteen patients implanted. No patients 
in that series were made pain free but all ten reported a definite difference from stimulation.16 In 1997, 
Kumar et al. reported on twelve patients with permanently implanted leads17: eight patients enjoyed 
near complete resolution of their symptoms and four also maintained good relief. 
Kemler et al. reported 23 additional cases with 78% of the patients reporting improvement.18 A later 
study19 compared patients randomized to SCS to those treated with physical therapy. In the SCS 
group, 67% of patients experienced significant pain relief which persisted at 6 months. However, 
no functional improvement was observed in either group. A 5-year follow-up on the SCS group 
indicated that the effects of SCS diminished over time for these patients.20 
Oakley and Weiner reported a prospective 
study of 19 patients with CRPS implanted with 
spinal cord stimulation systems.21 Of the ten 
patients in whom detailed long-term efficacy 
data was available, three reported full relief 
from their pain and seven, partial beneficial 
relief. 
Three additional prospective studies without 
matched controls have been reported.21-23 
Two of the studies reported success rates 
with an 84% overall success rate. The third 
study by Calvillo et al.22 reported a significant 
improvement in pain scores and a >50% 
reduction in narcotic use by 44% of subjects. In 
eight retrospective studies the overall success 
rate was 84% 192 patients.24 
Post-laminectomy syndrome aka 
Failed back surgery syndrome (FBSS)
Post-laminectomy syndrome is a broad term 
which can include pain localized to the lower 
lumbar region or the buttocks, persistent 
radicular pain, or diffuse lower extremity pain. 
Most published series distinguish between 
back and leg pain, but seldom define the 
details of the pain syndromes. SCS is accepted 
in the treatment of leg pain, but its widespread 
use for relief of pain in the lower lumbar area 
still remains to be defined. 
A technical challenge has been to provide 
stimulation in the low back, where paresthesia 
is often replaced over time by an unpleasant 
segmental band of stimulation from the 
thoracic roots. Previous pioneering work 
by Jay Law25, 26 has shown that stimulation 
in the low back can be obtained only if one 
uses multiple arrays of closely spaced bipolar 
electrodes at T9-T10. North et al. have shown 
that one single quadripolar electrode in 
midline has the ability to stimulate the axial 
low back.27 Flanking the cathode by lateral 
anodes also appears to increase the discomfort 
threshold theoretically.28
Marchand et al.29 conducted a prospective 
randomized controlled study examining patients 
with at least one prior surgery for chronic back 
pain secondary to trauma. Each patient used 
a SCS and acted as his or her own control. 
Spinal/Functional
1
Falowski MD: Spinal Cord Stimulation
Published by Jefferson Digital Commons, 2009
 JHN J O U R N A L 
Although a small trial, with only eight patients, 
pain scores were significantly reduced with SCS 
compared to placebo stimulation.
The longitudinal studies by North showed 
that in patients with post-surgical lumbar 
arachnoid or epidural fibrosis without 
surgically remediable lesions, SCS provided at 
least 50% pain relief in 53% of patients at 2.2 
years.30 North et al. also conducted a study 
randomizing patients with FBSS to either 
repeat back surgery or SCS surgery,33 allowing 
crossover after six months. Ten of fifteen 
patients crossed over from back surgery 
to SCS, while only two of twelve patients 
crossed over from SCS to back surgery.
Turner et al.31 systematically reviewed a total 
of 41 articles from 1966 to 1994 and noted 
that approximately 50-60% of patients with 
post-laminectomy greater than 50% pain relief 
was attained from the use of SCS. In 1996, 
Burchiel et al. conducted a prospective multi-
center study with one year follow-up and also 
reported 55% successful stimulation.32
Angina
There are well documented reports in the 
literature revealing uniformly good results 
using SCS to relieve anginal pain.34-38 Further, 
the results have been maintained in long term 
follow-up and have been substantiated by 
a reduction in the intake of nitrates as well. 
Interestingly, other findings have supported 
the evidence that SCS has effects that go 
beyond pain relief. The observations that 
there is less ST segment depression and that 
the exercise capacity, the time to angina and 
the recovery time all improve with stimulation 
may suggest that there is a reduction in 
ischemia. In a positron emission tomography 
study, a redistribution of myocardial flow in 
favor of ischemic parts of the myocardium 
has been demonstrated as a long term effect of 
spinal cord stimulation, both at rest and after 
pharmacologic stress induction.39 
Vulink et al. conducted a prospective study 
on quality of life changes in patients with 
refractory angina pectoris implanted with SCS. 
They found that both the pain and the health 
aspects of quality of life improved significantly 
after 3 months of SCS. Further, social, mental 
and physical aspects of quality of life were 
found improved after one year of SCS.40
Hautvast et al.41 implanted SCS in patients with 
stable angina pectoris and randomized them. 
One group’s remained inactivated while the 
other group was instructed to use the stimulator 
three times per day for one hour and with any 
angina attack. At 6 weeks, compared with 
controls, the treatment group had increased 
exercise duration and time to angina, and 
decreased anginal attacks and sublingual nitrate 
consumption. Also, observed was a decrease 
in ischemic episodes on EKG, as well as a 
decrease in observed ST segment depressions 
on exercise EKG. There was an increase in 
perceived quality of life and decrease in pain.
Mannheimer et al.42 randomized 104 patients 
accepted for CABG to receive either CABG 
(n=51) or SCS (n=53) in the ESBY study. 
This study demonstrated that patients 
randomized to SCS showed a greater than 
30% improvement in Nottingham Health 
Profile (NHP) scores compared with baseline, 
which was significant and comparable to the 
improvement shown by patients randomized 
to CABG.43 These results were consistent on 
follow up after four years. It is important to 
know that the five-year mortality of 27.9% 
in the ESBY study was similar between those 
receiving SCS and those who received CABG, 
with no difference in the percentage of cardiac 
deaths. The ESBY study showed that cardiac 
events were similar across the groups, but that 
there was significantly more cerebrovascular 
events observed in the CABG group.
Both groups experienced a significant 
reduction in both the number of angina attacks 
and the consumption of nitrates. There was 
no significant intergroup difference regarding 
these parameters. In another prospective 
study of 104 patients who underwent SCS 
implantation for refractory angina pectoris 
there was a significant decrease in angina 
episodes at rest, angina episodes with activity, 
and total angina episodes 44
DeJongste et al.36 randomized seventeen 
patients with angina to an active treatment 
group (i.e. SCS implantation) and a control 
group. The control group was followed for 
two months followed by SCS implantation. 
Both groups were followed for a total of 12 
months. This study also revealed a statistically 
significant reduction in the incidence of angina 
attacks and in the consumption of nitrates.
Five additional studies are reported to be pro-
spective but without matched controls.36, 40, 45-48 
Each of these revealed significant benefit from 
spinal cord stimulation. The benefit indices 
ranged from reduction in angina attacks, 
decrease nitrate consumption, decrease in 
NYHA grade and improvement in NHP grade.
Andersen et al. reported that out of 45 patients 
treated with SCS for anginal pain, there were 
three who had also survived a myocardial 
infarction49: all three patients noticed the pain 
to be different and unrelieved with SCS and 
all patients correctly guessed that the pain was 
due to a myocardial infarction. The authors 
concluded that SCS reduces the severity of 
anginal attack, but was unable to suppress the 
conduction and perception of cardiac pain 
signals which act as alarm signals of cardiac 
distress. Similarly, Murray et al. have shown 
that SCS for refractory angina is effective 
in preventing hospital admissions without 
masking the ischemic symptoms or leading to 
silent infarction.50
How SCS reduces angina is unclear. 
Hautvast et al.41 demonstrated no significant 
changes in heart rate variability after 6 wks, 
concluding that autonomic modulation of 
heart rate may not be the mechanism of 
action. There SCS may reduces myocardial 
ischemia via homogenization of myocardial 
blood perfusion.39,51 SCS can improve lactate 
metabolism in the heart muscle, and lactate 
metabolism, oxygen demand and blood 
flow in the coronary sinus.52 SCS does not 
effect variability in heart rates or cardiac 
arrhythmias.35, 53, 54
We do not know whether the pain relief is 
due to direct depression of the nociceptive 
signals in the spinal cord or whether there 
is secondary gain from a reduction in the 
ischemia.55,56 Foreman has shown that 
dorsal column stimulation inhibits the 
activity of spinothalamic tracts cells evoked 
by activation of the cardiac sympathetic 
afferents or by intracardiac bradykinin.14 
On the other hand the stimulation might 
producing a prolonged inhibition of the 
hyperactive sympathetic system, as was shown 
experimentally in the rat by Linderoth et al.15 
The most appropriate electrode location for 
the treatment of angina pectoris is most likely 
the lower cervical and upper thoracic region, 
although some have reported successful higher 
cervical placements.42 Another consideration 
is continuous versus cyclical use of SCS. In 
practice, patients using SCS for angina pectoris 
often use a low intensity stimulation for several 
hours per day for prophylactic purposes.57 
Recently, a randomized control study 
demonstrated improvement in functional 
status and symptoms in treatment arms with 
conventional or sub threshold stimulation 
in comparison to a low output placebo 
treatment arm.58 
Abdominal/Visceral Pain 
Syndromes
Approximately 20% of the population in 
United States have abdominal pain. There are 
many etiologies for abdominal pain including 
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gastrointestinal, genitourinary, musuloskeletal 
and nervous systems. Treatment modalities 
have included cognitive- behavioral, physical, 
and pharmacological therapies. Other more 
invasive therapies have extended to include 
celiac plexus blocks and celiac ganglia 
destruction. Some studies have demonstrated 
some localization in the spinal cord for visceral 
pain secondary to malignancy. Midline 
myelotomy through the dorsal columns at 
the level of T10 has shown success in eight 
patients with refractory pelvic cancer pain. 
This was also demonstrated in animal studies 
where dorsal column activity was observed in 
pelvic visceral nociception.59
Several studies have demonstrated the benefit 
of SCS in abdominal visceral disease. Ceballos 
et al.60 demonstrated reduction in pain scores 
and decrease in narcotic use in a patient treated 
for mesenteric ischemia. Krames et al.61 
described a patient treated for irritable bowel 
syndrome who was developing escalating pain 
and diarrhea. In the first 6 months there was 
a subjective decrease in pain on a 10-point 
scale from 9/10 to 2/10, with only two diarrhea 
episodes and with significant reduction in pain 
medications. There was some return of pain 
after ten month follow-up, but still a significant 
reduction in diarrhea. Khan et al.62 reported 
on the largest series with nine patients with 
refractory abdominal pain, all of whom had a 
significant improvement in pain scores as well 
as decreased narcotic use at six to eight month 
follow up.
Tiede et al. described treatment of refractory 
abdominal pain in two patients. Both patients 
had a significant history including multiple 
abdominal surgeries and failed conservative 
measures. Each patient had an element of 
postprandial abdominal pain with associated 
nausea and vomiting. In both patients the leads 
were placed at the T2 level with significant 
improvement in pain, decreased narcotic use 
and increase functioning, such as return to 
work63. Kapur et al.64 recently described relief 
of abdominal pain associated with colchicine 
intolerant or resistant patients with familial 
Mediterranean fever by placement of the 
electrodes at the lower thoracic levels.
More recent studies have looked at the 
treatment of visceral pelvic pain with 
reference to the dorsal columns and spinal 
cord stimulation. Kapural et al.65 reported 
on the value of neurostimulation for chronic 
visceral pelvic pain in six female patients with 
the diagnosis of long-standing pelvic pain. 
These patients had a history of endometriosis, 
multiple surgical explorations, and dyspareunia. 
At an average follow up of 30 months there was 
a significant decrease in the pain score with an 
average of more than 50% pain relief, with a 
decrease in opiate use.
Visceral innervation follows the embryo-
logic origin and location of the viscera and is 
arranged in viscerotomes, analogous to cuta-
neous dermatomes.66 The viscera obtain their 
innervation via the sympathetic and parasym-
pathetic pathways. The parasympathetics carry 
their afferents to anterior and posterior vagal 
trunks and are therefore not as amendable 
to spinal cord stimulation. The sympathetics 
carry nociceptive information from the viscera 
to spinal nerve roots making them a more 
viable target. The sympathetic afferents in the 
lower six thoracic and the upper three lumbar 
spinal segments have been shown to transmit 
painful impulses from the viscera 67.
Equipment (Electrodes and 
pulse generators)
There are various implantable technologies 
existing for SCS. These include trial percuta-
neous electrodes, permanent percutaneous 
electrodes, permanent plate electrodes, totally 
implantable rechargeable and non-recharge-
able pulse generators (IPG) and radiofrequency 
(RF) driven pulse generators.
Percutaneous electrodes
Percutaneous electrodes can be inserted without 
much dissection and can easily be removed 
in the implanting physician’s office. During 
implantation, these electrodes can be advanced 
over several segments in the epidural space, 
allowing testing of several spinal cord levels to 
assess for optimal electrode position.
Contemporary percutaneous electrodes are 
slim electrodes, only a few millimeters in 
diameter and containing four or eight contacts 
(referred to as either quadripolar or octopolar 
electrodes). Choosing the particular electrode 
entails deciding how many segments of the spi-
nal cord are to be covered, with larger spacing 
allowing broader coverage. Alternatively, closer 
spacing allows better steering and electric field 
shaping. Additionally, multiple parallel elec-
trodes and different configuration matrices 
can be constructed which can create extremely 
focused electrical fields. 
Spinal/Functional
Figure 2
The above graphic on the left shows a patient who had an L4,5 and L5,S1 anterior posterior 
fusion for back and leg pain from lumbar spondylolisthesis.  She continued to have 
both back and leg pain despite a successful lumbar reconstruction.  An ANS (Advanced 
Neuromodulation System) tripole electrode was implanted in the thoracic spine.  There are 
three columns of electrodes. The middle covers the back and the lateral columns provide 
stimulation into the legs. The electrode was placed in the operating room with fluoroscopy 
and intra-operative EMG monitoring under general anesthesia.
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Plate electrodes
Plate-type electrodes (or ribbon electrodes, 
paddle electrodes, or laminotomy electrodes) 
require a surgical procedure, laminotomy, and 
implantation under direct vision. Implantation 
under direct vision may be safer in the upper 
thoracic and cervical areas, where there is 
a risk of damaging the spinal cord with the 
large bore Touhy needle. Most implants can 
be done through a skin incision between 2.5 
cm and 4 cm long, depending on the size of 
the patient and spinal anatomy. The amount 
of bony removal is usually minimal. 
The main advantage of plate electrodes is 
their greater inherent stability, with less to 
migrate. Plate electrodes are also more energy 
efficient. Multiple arrays or different electrode 
configurations can be constructed with plate 
electrodes. As with percutaneous leads, there 
are varying lengths, and shapes—such as 
curved leads and hinged leads, all designed to 
help facilitate insertion and tailor the electrode 
selection to the patient. They are a preferred 
option in the case of previous spine surgery at 
the implant levels. 
North et al. have published on comparison 
between plate and percutaneous electrodes.68 
Laminectomy electrode placement, although 
more invasive than percutaneous placement, 
yielded significantly better clinical results in 
patients with failed back surgery syndrome 
at up to 3-year follow up. Clinical success was 
defined as at least 50% pain relief and patient 
satisfaction with treatment. Secondary outcome 
measures were ability to perform various 
activities of daily living, neurological function, 
and analgesic use. There is some theoretical 
evidence that shaping of the electrical field is 
possible with even more complex electrode 
arrays. Holsheimer et al.69 concluded that the 
transverse tripolar system enabled finer control 
of paresthesia. Electrical field steering could 
change the paresthesia area completely. Using 
transverse tripolar configurations increases 
the threshold for stimulation of dorsal roots. 
This results in a wider therapeutic range, wider 
paresthesia coverage, and a greater probability 
to fully cover the painful area with paresthesia.
Rechargeable and Non-rechargeable 
Pulse Generators and Radio-
Frequency Receivers
Electrical stimulation consists of rectangular 
pulses delivered to the epidural space through 
implanted electrode via a power source. Two 
basic types of systems are currently available: 
an Internal Pulse Generator (IPG; also 
called the battery) or a radiofrequency (RF) 
coupled pulse generator with an implantable 
receiver. The later has largely fallen out of 
favor due to the inconveniences of having an 
external power source. However, the advent 
of the totally implantable, rechargeable 
pulse generator has surmounted the power 
requirement issues, which were previously the 
main RF advantage.
The totally implantable pulse generator 
contains a lithium battery. Activation 
and control occur through an external 
transcutaneous telemetry device. The IPG 
can be turned on and off through a small 
controller which the patient can carry. The 
controller also allows some control over 
the stimulation parameters. More extensive 
control of the unit can be achieved through a 
small portable unit which can be programmed 
by the physician. Life span of the battery varies 
with usage and with the utilized parameters 
(voltage, rate, pulse width, etc.). Most patients 
can expect that the battery will last from 2.5 
to 4.5 years. Available lithium powered pulse 
generators allow stimulation with fine control 
of stimulation amplitude, pulse width and 
rate. Replacement of the battery requires a 
surgical procedure which is usually performed 
on an outpatient basis. 
Radio frequency (RF) driven systems, 
consist of a passive receiver, implanted 
subcutaneously, and a transmitter which is 
worn externally. An antenna applied to the 
skin in correspondence of the receiver is 
connected to the transmitter, which sends 
the stimulation signals transcutaneously. RF 
systems have the inconvenience of having 
to wear the antenna and the radio-receiver, 
replacing the batteries on a regular basis, 
and ensuring proper contact of the antenna 
on the skin. These issues may be critical 
for individuals with limited upper-limb 
motor function. Other patients, particularly 
individuals who have reflex sympathetic 
dystrophy (RSD), may not tolerate the antenna 
taped to the skin. However, what one loses in 
convenience, however, is gained in power 
and flexibility. Currently only RF systems 
can provide a stimulation rate up to 1,400 
Hz. This might be beneficial in some patients 
with neuropathic chronic pain syndromes70 
as well as in patients with extrapyramidal 
motor disorders. 
Complications
With the proper expertise, permanent 
complications are rare.71 The most serious 
complications are paralysis or other severe 
neurological deficits, which are risks 
inherent in any spine surgery. Infection of 
the implanted hardware has occurred with 
a 3-5% rate. Persistent pain at the implant 
site has been seen in about 5% of patients. 
Recalcitrant cerebrospinal fluid leakage has 
been encountered in a few patients, requiring 
multiple surgical revisions. Breakage or 
malfunction of the implanted hardware, 
particularly the electrodes and the subcutaneous 
extension cables has been encountered in 
about 10% of the implanted systems. Painful 
stimulation, necessitating either repositioning 
or removal of the electrode, has also been 
reported in a number of cases.
Conclusions
The treatment of chronic pain remains 
challenging. Spinal cord stimulation has been 
performed for over 30 years, and slow but 
steady progress with this technology has been 
made. As the equipment and stimulation 
parameters are improved, selection criteria 
have been better defined and are slowly being 
expanded. More importantly, experience in 
the technique and the equipment has made 
SCS a much more reliable and safe modality. 
Like all the modalities performed for chronic 
pain management, its results are favorable. 
It is important to remember that the goal of 
neurostimulation is to reduce pain, rather than 
to eliminate pain. It has been shown to have a 
50% improvement in pain relief, and reduce 
the use of more medications Very few other 
invasive modalities can claim this success rate 
with a few years of follow-up.
Careful follow-up of the patients is necessary for 
successful long-term satisfaction. Equipment 
related problems can arise at any time after 
implantation, such as discomfort at the 
pulse generator/radio receiver site, electrode 
breakage or migration, infection, etc., and an 
open dialogue with the patients is vital for the 
continuing successful implementation of the 
modality. Spinal cord stimulation has earned a 
well established and firm role in contemporary 
chronic pain management.
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